Strategy

Why private equity is investing in biopharma

Read more

Dual inhibition of intracellular enzymes

Read more

The use of patient registries for regulatory purposes

Read more

Brain health and disease in the digital era

Read more

How bacteria evade treatment

Read more

Combining biologics and small molecules for cancer

Read more

Microsoft pioneers biological computing

Read more

The shift towards value-based pricing for medicines

Read more

NCI and industry: Moving innovations from the lab to patients

Read more

Europe's pharma groups change product mix

Read more